Clinical Trials Directory

Trials / Completed

CompletedNCT05591144

Short-term Oral Prednisone for Acute Subjective Tinnitus

Investigating the Efficacy of Short-term Oral Prednisone Therapy on Acute Subjective Tinnitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
146 (actual)
Sponsor
Eye & ENT Hospital of Fudan University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to investigate the efficacy of oral steroids in the acute tinnitus population. Participants will receive appropriate dosages of short-term prednisone and/or oral Ginkgo Biloba tablets.

Detailed description

Researchers will compare the intervention group and placebo-control group to see whether short-term systemic steroid therapy is effective for acute tinnitus.

Conditions

Interventions

TypeNameDescription
DRUGPrednisone tabletThe dose selection of oral prednisone is the maximum daily dose based on weight for 4 days, followed by a taper every 2 days, with the maximum duration to 14 days.
DRUGGinkgo Biloba ExtractGinkgo biloba extracts are traditional Chinese medicine, which can improve microcirculation and provide good ameliorating effects for the treatment of tinnitus

Timeline

Start date
2022-10-30
Primary completion
2023-01-22
Completion
2024-02-03
First posted
2022-10-24
Last updated
2025-02-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05591144. Inclusion in this directory is not an endorsement.